Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Gene Therapy · Brazil · 2025-05-23

Processing Time
49 days
Decision Date
2025-05-23
Location
Ohio
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop novel models of neuronal cells and apply gene therapy for the treatment of neuromuscular disorders. Her work focuses on using AAV-based gene therapies and CRISPR-adapted gene editing to enhance muscle regeneration and restore function in patients with conditions like DMD and CMD.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses neuromuscular disorders that cost the U.S. healthcare system billions annually, such as ALS and DMD.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong record of influence with 360 citations and highly cited articles in top-tier journals like The FASEB Journal.

3 Waiver Benefit Met

The petitioner's research provides biologically precise and increasingly affordable gene therapy modalities that outweigh the need for a job offer.

Why This Petition Was Approved

The petition was approved based on the petitioner's 15 peer-reviewed journal articles, 17 abstracts, and 3 book chapters which accumulated 360 citations. Evidence showed her publications rank in the top 10-20% of cited works in her field, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Analyst

Biotechnology · China

WeGreened EB-2 (NIW) approved
Indiana 122 days 2025-01-28
The petitioner proposes to develop and refine gene editing therapies, specifically utilizing CRISPR-Cas9 technology, to target the genetic roots of congenital neuromuscular disorders. Her work focuses on identifying underlying genetic mechanisms of hereditary muscular atrophy to create precise clinical interventions. The goal is to improve patient outcomes and reduce the long-term economic burden of diseases like Duchenne muscular dystrophy on the U.S. healthcare system.
View Case

Postdoctoral Researcher

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
California 249 days 2025-05-28
The petitioner proposes to develop advanced biological tools for genetic and molecular cell interfacing, specifically focusing on high-precision CRISPR base editors and synthetic protein biomarkers. This work aims to refine viral vector delivery systems to enable targeted, non-invasive gene therapies for complex neurological diseases.
View Case

Scientist

Biotechnology · Zimbabwe

WeGreened EB-2 (NIW) approved
Massachusetts 297 days 2025-03-06
The petitioner proposes to develop safe and effective gene therapies and delivery systems to improve treatment options for rare and complex disorders. Her work specifically focuses on uncovering how protofibrils contribute to neuronal damage in Alzheimer’s disease to support the development of targeted drug therapies.
View Case

Doctor

Healthcare · Israel

WeGreened EB-2 (NIW) approved
Ohio 56 days 2024-12-17
The petitioner proposes to advance the understanding of complex genetic disorders through the development of innovative genetic engineering models and tailored drug design methodologies. This work specifically focuses on investigating somatic mutations in the brains of individuals with Alzheimer’s disease to identify new pathways for diagnosis and therapeutic intervention. The endeavor aims to support the medical community in treating neurodegenerative processes and syndromic autism.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Brazil

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 49 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Brazil All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist